CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant

The emergence of new SARS-CoV-2 variants represents a constant threat to world public health. The SARS-CoV-2 Delta variant was identified in late 2020 in India; since then, it has spread to many other countries, replacing other predominant lineages and raising concerns about vaccination efficiency....

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Marcilio Jorge Fumagalli, Luiza Antunes Castro-Jorge, William Marciel de Souza, Patrick Orestes de Azevedo, Alana Witt Hansen, Ricardo Tostes Gazzinelli, Benedito Antônio Lopes da Fonseca, Fernando Rosado Spilki, Luiz Tadeu Moraes Figueiredo
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-02-01
Sarja:	Viruses
Aiheet:	SARS-CoV-2 Delta variant Gamma variant CoronaVac ChAdOx1 vaccination
Linkit:	https://www.mdpi.com/1999-4915/14/2/305
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!